Advertisement
Screener

KORU MEDICAL SYSTEMS, INC. (KRMD) EBITDA

KORU MEDICAL SYSTEMS, INC. (KRMD) EBITDA

  • 2026-06-30: Basis Reported; EBITDA $837,022.00; Operating income (m); Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA -$667,392.00; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA -$367,930.00; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA -$663,197.00; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2010-08-31 to 2026-06-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$837,022.00(m)(m)(m)6.95%(m)$216.11K*$4.20M$1.07M$5.94M$5.80K
2026-03-31Reported-$667,392.00(m)(m)(m)-5.67%(m)$14.66K$4.53M$1.32M$6.58M(m)
2025-12-31Reported-$367,930.00(m)(m)(m)-3.38%(m)(m)(m)(m)(m)(m)
2025-09-30Reported-$663,197.00(m)(m)(m)-6.38%(m)$65.46K*$4.14M$933.11K$5.99M-$150.00
2025-06-30Reported-$103,168.00(m)(m)(m)-1.01%(m)-$460.34K*$3.72M$1.19M$5.38M$17.36K
2025-03-31Reported-$1.03M(m)(m)(m)-10.67%(m)-$237.47K$3.59M$1.11M$5.96M(m)
2024-12-31Reported-$1.38M(m)(m)(m)-15.59%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$1.48M(m)(m)(m)-18.04%(m)-$923.95K*$2.99M$1.53M$5.13M(m)
2024-06-30Reported-$974,170.00(m)(m)(m)-11.56%(m)$11.34K*$2.95M$1.13M$5.32M(m)
2024-03-31Reported-$1.73M(m)(m)(m)-21.10%(m)-$346.72K$3.09M$1.48M$5.36M(m)
2023-12-31Reported-$1.97M(m)(m)(m)-27.40%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$1.58M(m)(m)(m)-22.49%(m)-$1.17M*$2.66M$1.29M$4.62M-$300.25K
2023-06-30Reported-$3.01M(m)(m)(m)-43.42%(m)-$153.94K*$3.05M$1.60M$5.30M-$600.00K
2023-03-31Reported-$2.84M(m)(m)(m)-38.47%(m)-$4.66M$3.25M$1.56M$5.43M-$577.40K
2022-12-31Reported-$2.32M(m)(m)(m)-31.64%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$1.37M(m)(m)(m)-17.59%(m)-$2.12M*$3.44M$862.15K$4.83M-$271.50K
2022-06-30Reported-$3.49M(m)(m)(m)-53.27%(m)-$2.87M*$3.20M$1.30M$5.53M-$710.26K
2022-03-31Reported-$3.02M(m)(m)(m)-48.32%(m)-$1.75M$2.62M$1.15M$5.49M-$597.60K
2021-12-31Reported-$2M(m)(m)(m)-30.81%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$1.21M(m)(m)(m)-19.97%(m)-$826.23K*$2.54M$800.02K$3.90M-$238.10K
2021-06-30Reported-$1.26M(m)(m)(m)-22.84%(m)-$170.50K*$2.32M$386.88K$4.09M-$245.32K
2021-03-31Reported-$2.1M(m)(m)(m)-38.63%(m)-$2.61M$2.20M$336.84K$4.99M-$942.36K
2020-12-31Reported-$1.04M(m)(m)(m)-25.72%(m)(m)(m)(m)(m)(m)
2020-09-30Reported$474,463.00(m)(m)(m)7.80%(m)-$1.74M*$2.14M$390.42K$3.08M$143.35K
2020-06-30Reported-$937,061.00(m)(m)(m)-12.16%(m)$2.55M*$2.80M$298.20K$3.20M$30.92K
2020-03-31Reported$670,047.00(m)(m)(m)10.59%(m)$153.24K$2.54M$256.02K$2.86M$141.93K
2019-12-31Reported-$72,009.00(m)(m)(m)-1.16%(m)(m)(m)(m)(m)(m)
2019-09-30Reported$907,258.00(m)(m)(m)13.71%(m)$981.89K*$2.23M$170.26K$2.44M$186.68K
2019-06-30Reported$122,047.00(m)(m)(m)2.28%(m)-$438.68K*$1.87M$178.24K$2.05M$24.68K
2019-03-31Reported-$31,388.00(m)(m)(m)-0.63%(m)-$1.05M$1.93M$101.96K$2.48M-$22.10K
2018-12-31Reported-$355,928.00(m)(m)(m)-8.33%(m)(m)(m)(m)(m)(m)
2018-09-30Reported$561,031.00(m)(m)(m)12.34%$94.82K*$397.11K*$1.66M$126.92K$1.92M$103.26K
2018-06-30Reported$692,990.00(m)(m)(m)15.39%$89.04K*$968.90K*$1.76M$23.96K$2.02M$126.95K
2018-03-31Reported$575,707.00(m)(m)(m)14.27%$4.14K-$13.11K$1.57M$9.85K$1.88M$107.74K
2017-09-30Reported$469,895.00(m)(m)(m)12.21%$71.51K*$767.92K*$1.47M$14.85K$1.89M$137.40K
2017-06-30Reported$267,123.00(m)(m)(m)6.98%$26.92K*-$414.30K*$1.53M$24.84K$2.01M$76.96K
2017-03-31Reported$280,939.00(m)(m)(m)7.72%$62.52K$143.45K$1.54M$45.91K$1.78M$97.83K
2017-02-28Reported-$61,720.00(m)(m)(m)-2.08%(m)(m)(m)(m)(m)(m)
2016-11-30Reported-$29,215.00(m)(m)(m)-0.91%$31.74K*(m)(m)$59.14K$2.03M-$53.22K
2016-09-30Reported-$156,661.00(m)(m)(m)-4.86%(m)(m)(m)$75.20K$2.11M-$78.22K
2016-08-31Reported-$45,258.00(m)(m)(m)-1.44%$50.79K*(m)(m)$67.69K$1.93M-$41.85K
2016-06-30Reported-$388,417.00(m)(m)(m)-13.89%(m)(m)(m)$57.40K$2.12M-$164.83K
2016-05-31Reported-$299,446.00(m)(m)(m)-10.01%$54.65K(m)(m)$56.67K$2.18M-$119.90K
2016-02-29Reported$530,731.00(m)(m)(m)16.06%(m)(m)(m)(m)(m)(m)
2015-11-30Reported$359,489.00(m)(m)(m)11.43%$6.23K*(m)(m)$51.56K$1.70M$86.68K
2015-08-31Reported$576,875.00(m)(m)(m)18.22%$38.77K*$693.13K*(m)$38.71K$1.39M$173.19K
2015-05-31Reported-$14,145.00(m)(m)(m)-0.54%$61.34K$11.10K(m)$53.66K$1.48M-$32.80K
2015-02-28Reported$534,445.00(m)(m)(m)15.50%(m)(m)(m)(m)(m)(m)
2014-11-30Reported$205,978.00(m)(m)(m)7.76%$154.49K*$172.19K*(m)$116.89K$1.26M$19.40K
2014-08-31Reported$390,054.00(m)(m)(m)15.57%$306.14K*-$45.69K*(m)$158.42K$1.09M$105.70K
2014-05-31Reported$300,789.00(m)(m)(m)11.41%$91.43K$265.69K(m)$131.40K$1.09M$86.10K
2014-02-28Reported$568,840.00(m)(m)(m)21.59%(m)(m)(m)(m)(m)(m)
2013-11-30Reported$298,592.00(m)(m)(m)13.70%$13.91K*$101.10K*(m)$50.86K$975.73K$83.73K
2013-08-31Reported$193,162.00(m)(m)(m)9.62%$64.76K*$283.58K*(m)$43.12K$963.79K$47.23K
2013-05-31Reported$180,036.00(m)(m)(m)9.59%$68.23K$214.42K(m)$37.75K$951.16K$38.29K
2013-02-28Reported$343,071.00(m)(m)(m)17.17%(m)(m)(m)(m)(m)(m)
2012-11-30Reported$138,720.00(m)(m)(m)6.70%$117.01K*$126.21K*(m)$36.06K$1.11M$28.96K
2012-08-31Reported$584,926.00(m)(m)(m)29.97%(m)(m)(m)(m)(m)(m)
2012-05-31Reported$186,658.00(m)(m)(m)10.70%$121.90K$102.81K(m)$38.38K$881.77K$47.30K
2012-02-29Reported$582,703.00(m)(m)(m)28.66%(m)(m)(m)(m)(m)(m)
2011-11-30Reported$253,310.00(m)(m)(m)16.87%$114.73K*$86.53K*(m)$26.61K$631.98K$127.17K
2011-08-31Reported$202,846.00(m)(m)(m)14.89%(m)(m)(m)(m)(m)(m)
2011-05-31Reported$354,280.00(m)(m)(m)23.71%$31.46K$346.62K(m)$12.73K$586.78K$141.26K
2011-02-28Reported$607,813.00(m)(m)(m)37.89%(m)(m)(m)(m)(m)(m)
2010-11-30Reported$306,498.00(m)(m)(m)24.44%$13.06K*$364.16K*(m)$8.44K$528.18K$117.33K
2010-08-31Reported$194,718.00(m)(m)(m)18.04%(m)(m)(m)$10.39K$507.95K$70.22K

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$2.16M(m)(m)(m)-5.26%(m)$462.40K$15.52M$4.39M$23.38M$21.89K
2024-12-31Reported-$5.56M(m)(m)(m)-16.52%(m)-$319.72K$12.31M$5.26M$21.63M$2.89K
2023-12-31Reported-$9.4M(m)(m)(m)-32.96%(m)-$4.89M$11.81M$5.74M$20.37M$3.97M
2022-12-31Reported-$10.19M(m)(m)(m)-36.54%(m)-$5.40M$12.53M$4.96M$20.61M-$2.01M
2021-12-31Reported-$6.57M(m)(m)(m)-27.95%(m)-$4.32M$9.72M$2.47M$17.86M-$1.80M
2020-12-31Reported-$836,190.00(m)(m)(m)-3.46%(m)-$743.32K$9.24M$1.30M$12.03M-$17.80K
2019-12-31Reported$925,908.00(m)(m)(m)4.00%(m)$320.62K$8.31M$740.48K$9.77M$132.07K
2018-12-31Reported$1.47M(m)(m)(m)8.49%(m)$1.48M$6.54M$241.12K$8.20M$266.38K
2017-02-28Reported-$435,640.00(m)(m)(m)-3.54%$203.13K-$331.62K(m)$237.49K$7.77M-$241.70K
2016-02-29Reported$1.45M(m)(m)(m)11.86%$121.78K(m)(m)$207.28K$5.94M$359.71K
2015-02-28Reported$1.43M(m)(m)(m)12.73%$591.41K$826.10K(m)$468.15K$4.79M$321.42K
2014-02-28Reported$1.24M(m)(m)(m)14.26%$188.69K$954.39K(m)$218.15K$3.85M$307.02K
2013-02-28Reported$1.25M(m)(m)(m)16.14%$563.57K$784.79K(m)$147.58K$3.54M$312.35K
2012-02-29Reported$1.39M(m)(m)(m)21.80%$236.24K$560.60K(m)$90.33K$2.66M$465.29K
2011-02-28Reported$1.26M(m)(m)(m)25.62%$200.52K$1.03M(m)$35.52K$1.97M$489.03K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lucid Diagnostics Inc. (LUCD)United States$0.170B
Apyx Medical Corp (APYX)United States$0.120B-21.85
Profound Medical Corp. (PROF)$0.206B-7.37
Microbot Medical Inc. (MBOT)$0.089B-7.97
LENSAR, Inc. (LNSR)United States$0.087B2.02
Neuronetics, Inc. (STIM)United States$0.216B-3.25
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
Pulmonx Corp (LUNG)United States$0.082B-1.16
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18